The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
AIkido Pharma Inc(NASDAQ:AIKI) 
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC...
Website: http://www.aikidopharma.com
Full Time Employees: 4 (May 2021)
CEO: Anthony C. Hayes
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
AIkido Pharma Days Receivable Outstanding ttm (DSO)
AIkido Pharma Op Cashflow Per Share ttm
AIkido Pharma Free Cashflow Per Share ttm
AIkido Pharma Cash Per Share ttm
AIkido Pharma P/S ratio ttm
AIkido Pharma (GAAP) P/E ratio ttm
AIkido Pharma P/B ratio ttm
No extra charts and metrics for this ticker.